Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

60 Degrees Pharmaceuticals (SXTPW) Change in Accured Expenses (2022 - 2025)

Historic Change in Accured Expenses for 60 Degrees Pharmaceuticals (SXTPW) over the last 4 years, with Q3 2025 value amounting to $445639.0.

  • 60 Degrees Pharmaceuticals' Change in Accured Expenses rose 82812.45% to $445639.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $785379.0, marking a year-over-year increase of 7608.84%. This contributed to the annual value of $501412.0 for FY2024, which is 33350.38% up from last year.
  • Latest data reveals that 60 Degrees Pharmaceuticals reported Change in Accured Expenses of $445639.0 as of Q3 2025, which was up 82812.45% from -$252166.0 recorded in Q2 2025.
  • 60 Degrees Pharmaceuticals' Change in Accured Expenses' 5-year high stood at $445639.0 during Q3 2025, with a 5-year trough of -$788990.0 in Q3 2023.
  • In the last 4 years, 60 Degrees Pharmaceuticals' Change in Accured Expenses had a median value of $100153.0 in 2024 and averaged $77811.2.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first plummeted by 191841.02% in 2023, then surged by 102681.24% in 2025.
  • 60 Degrees Pharmaceuticals' Change in Accured Expenses (Quarter) stood at $226100.0 in 2022, then rose by 21.45% to $274603.0 in 2023, then increased by 20.17% to $330001.0 in 2024, then soared by 35.04% to $445639.0 in 2025.
  • Its Change in Accured Expenses was $445639.0 in Q3 2025, compared to -$252166.0 in Q2 2025 and $261905.0 in Q1 2025.